Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle.
Ferraz AC, Matheussi F, Szawka RE, Rizelio V, Delattre AM, Rigon P, Hermel Edo E, Xavier LL, Achaval M, Anselmo-Franci JA. Ferraz AC, et al. Neurochem Res. 2008 Jul;33(7):1238-46. doi: 10.1007/s11064-007-9575-7. Epub 2008 Feb 9. Neurochem Res. 2008. PMID: 18259859
Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease.
Rizelio V, Szawka RE, Xavier LL, Achaval M, Rigon P, Saur L, Matheussi F, Delattre AM, Anselmo-Franci JA, Meneses M, Ferraz AC. Rizelio V, et al. Among authors: ferraz ac. Braz J Med Biol Res. 2010 Jan;43(1):85-95. doi: 10.1590/s0100-879x2009007500020. Epub 2009 Dec 4. Braz J Med Biol Res. 2010. PMID: 19967265 Free article.
Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease.
Delattre AM, Kiss A, Szawka RE, Anselmo-Franci JA, Bagatini PB, Xavier LL, Rigon P, Achaval M, Iagher F, de David C, Marroni NA, Ferraz AC. Delattre AM, et al. Among authors: ferraz ac. Neurosci Res. 2010 Mar;66(3):256-64. doi: 10.1016/j.neures.2009.11.006. Epub 2009 Nov 24. Neurosci Res. 2010. PMID: 19941911
Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase.
Mori MA, Delattre AM, Carabelli B, Pudell C, Bortolanza M, Staziaki PV, Visentainer JV, Montanher PF, Del Bel EA, Ferraz AC. Mori MA, et al. Among authors: ferraz ac. Nutr Neurosci. 2018 Jun;21(5):341-351. doi: 10.1080/1028415X.2017.1290928. Epub 2017 Feb 21. Nutr Neurosci. 2018. PMID: 28221817
17β-estradiol replacement in young, adult and middle-aged female ovariectomized rats promotes improvement of spatial reference memory and an antidepressant effect and alters monoamines and BDNF levels in memory- and depression-related brain areas.
Kiss A, Delattre AM, Pereira SI, Carolino RG, Szawka RE, Anselmo-Franci JA, Zanata SM, Ferraz AC. Kiss A, et al. Among authors: ferraz ac. Behav Brain Res. 2012 Feb 1;227(1):100-8. doi: 10.1016/j.bbr.2011.10.047. Epub 2011 Nov 7. Behav Brain Res. 2012. PMID: 22085882
Multiple intranigral unilateral LPS infusion protocol generates a persistent cognitive impairment without cumulative dopaminergic impairment.
Delattre AM, Carabelli B, Mori MA, Pudell C, da Silva DR, Menezes I, Kempe PR, Staziaki PV, Dombrowski PA, da Cunha C, Lima MM, Ferraz AC. Delattre AM, et al. Among authors: ferraz ac. CNS Neurol Disord Drug Targets. 2013 Nov;12(7):1002-10. doi: 10.2174/18715273113129990074. CNS Neurol Disord Drug Targets. 2013. PMID: 23844681
80 results